CA
CA · CA · CA-DIN-02513161
MAGNESIUM SULFATE INJECTION, BP 49.3%
ATC B05XA05
Last synced from Health Canada Drug Product Database (Canada) on
Identification
ManufacturerBAXTER CORPORATION
CountryCA (CA)
ATC codeB05XA05
Dispensing—
ReimbursedNo
SourceHealth Canada Drug Product Database (Canada)
Last synced6/11/2026
Packs · 0
No packs registered.
Annotations
No annotations yet.
Raw payload (JSON)
{
"din": "02513161",
"form": "SOLUTION",
"class": "Human",
"routes": [
"INTRAVENOUS"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "B05XA05",
"schedule": [
"Ethical"
],
"drug_code": "100227",
"strengths": [
"493 MG"
],
"ahfs_class": null,
"substances": [
"MAGNESIUM SULFATE"
],
"product_categorization": null
}Related drugs
Other records sharing ATC code B05XA05.
- NOAddex-MagnesiumFresenius Kabi Norge AS
- ISAddex-MagnesiumFresenius Kabi AB
- FIAddex-MagnesiumsulfaattiFresenius Kabi AB
- PLInj. Magnesii Sulfurici 20% PolpharmaZakłady Farmaceutyczne POLPHARMA S.A.
- IEMagnesium Sulfate 50 % w/v Solution for Injection/Concentrate for solution for infusionEthypharm
- CAMAGNESIUM SULFATE IN WATER FOR INJECTIONBAXTER CORPORATION
- CAMAGNESIUM SULFATE INJECTION USPSANDOZ CANADA INCORPORATED
- CAMAGNESIUM SULFATE INJECTION, USPFRESENIUS KABI CANADA LTD
Access this data programmatically
Query MAGNESIUM SULFATE INJECTION, BP 49.3% and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.